A detailed history of Schonfeld Strategic Advisors LLC transactions in Schrodinger, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,212,383 shares of SDGR stock, worth $26.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,212,383
Previous 163,500 641.52%
Holding current value
$26.1 Million
Previous $5.85 Million 459.27%
% of portfolio
0.23%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$24.74 - $35.13 $25.9 Million - $36.8 Million
1,048,883 Added 641.52%
1,212,383 $32.7 Million
Q4 2023

Feb 14, 2024

BUY
$21.62 - $37.21 $1.19 Million - $2.05 Million
55,166 Added 50.92%
163,500 $5.85 Million
Q3 2023

Nov 14, 2023

SELL
$27.34 - $55.37 $2.06 Million - $4.18 Million
-75,416 Reduced 41.04%
108,334 $3.06 Million
Q2 2023

Aug 14, 2023

SELL
$26.1 - $49.92 $277,965 - $531,648
-10,650 Reduced 5.48%
183,750 $9.17 Million
Q1 2023

May 15, 2023

BUY
$18.09 - $27.61 $2.47 Million - $3.77 Million
136,700 Added 236.92%
194,400 $5.12 Million
Q4 2022

Feb 14, 2023

BUY
$16.24 - $26.38 $677,207 - $1.1 Million
41,700 Added 260.63%
57,700 $1.08 Million
Q3 2022

Nov 14, 2022

BUY
$23.95 - $34.71 $383,200 - $555,360
16,000 New
16,000 $399,000
Q1 2021

May 17, 2021

SELL
$64.61 - $113.09 $2.82 Million - $4.93 Million
-43,630 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$48.06 - $84.4 $560,475 - $984,272
11,662 Added 36.48%
43,630 $3.46 Million
Q3 2020

Nov 16, 2020

BUY
$46.87 - $93.33 $1.31 Million - $2.6 Million
27,900 Added 685.84%
31,968 $2,000
Q2 2020

Aug 14, 2020

BUY
$36.12 - $91.57 $146,936 - $372,506
4,068 New
4,068 $373,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.33B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.